Ethiopia Malaria Vaccine Rollout: Africa’s 23rd Nation
- Ethiopia has initiated a nationwide malaria vaccination program alongside a large-scale distribution of insecticide-treated mosquito nets, targeting children in 58 high-burden districts.
- On September 18, 2025, Ethiopia officially launched its malaria vaccine program in Turmi, located in the South Omo Zone.
- The Africa Centres for Disease Control and Prevention (Africa CDC) is spearheading the rollout,providing 186,000 doses of the vaccine and over 12 million mosquito nets.
“`html
Ethiopia Launches First Malaria Vaccine, Bolsters Prevention Efforts
Table of Contents
Ethiopia has initiated a nationwide malaria vaccination program alongside a large-scale distribution of insecticide-treated mosquito nets, targeting children in 58 high-burden districts. This marks a significant step in the country’s fight against the disease.
Vaccine Rollout and Distribution Details
On September 18, 2025, Ethiopia officially launched its malaria vaccine program in Turmi, located in the South Omo Zone. The initiative combines vaccination with the distribution of insecticide-treated nets, providing a dual-pronged approach to protect children in 58 districts identified as having the highest malaria burden.This is a novel approach; previous malaria vaccine introductions in other African nations were integrated into existing immunization schedules.
The Africa Centres for Disease Control and Prevention (Africa CDC) is spearheading the rollout,providing 186,000 doses of the vaccine and over 12 million mosquito nets. Ethiopia is now the 23rd country in Africa to introduce malaria vaccination into its public health strategy, demonstrating a growing continental commitment to combating the disease.
Impact and Expert Commentary
“The introduction of the malaria vaccine in Ethiopia marks a historic step for the country in the fight against this devastating disease,” stated Agonafer Tekalegne, Country Director of Malaria Consortium Ethiopia. “It strengthens our collective efforts to move closer to a future where no child has to suffer or die from malaria.”
Malaria remains a significant public health concern in Ethiopia, disproportionately affecting children under five years of age. According to the World Health Organization (WHO), Ethiopia accounted for 3% of global malaria cases in 2022. The vaccine, combined with preventative measures like mosquito nets, is expected to significantly reduce the incidence of the disease and associated mortality rates.
Ethiopia’s Malaria Burden: A statistical Overview
The following table provides a snapshot of Ethiopia’s malaria situation, based on data from the Malaria Consortium and the WHO Global Health Observatory:
| Indicator | 2022 Estimate |
|---|---|
| Total Malaria Cases | Approximately 4.7 million |
| Malaria-Related Deaths | Approximately 3,000 |
| Proportion of Cases in Children Under 5 | Approximately 60% |
| Areas with Consistent Malaria Transmission | Approximately 75% of the land area |
Looking Ahead: Challenges and Opportunities
while the vaccine rollout is a major achievement, challenges remain. Ensuring equitable access to the vaccine and nets across all 58 districts, especially in remote and underserved areas, will be crucial. Sustained funding and robust monitoring systems are also essential for the long-term success of the program.
The introduction of the malaria vaccine in Ethiopia represents a significant prospect to accelerate progress towards malaria elimination